Cymulate CMO Gily Netzer shares her experience with the discovery she carried the mutated BRCA1 gene (responsible for breast cancer) and its intersection with cybersecurity.
Read more in Cybercrime Magazine.
Cymulate CMO Gily Netzer shares her experience with the discovery she carried the mutated BRCA1 gene (responsible for breast cancer) and its intersection with cybersecurity.
Read more in Cybercrime Magazine.